Reaction Details |
| Report a problem with these data |
Target | Alpha-2A adrenergic receptor [16-465] |
---|
Ligand | BDBM50201046 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_422965 (CHEMBL909867) |
---|
Ki | >1000±n/a nM |
---|
Citation | Cesari, N; Biancalani, C; Vergelli, C; Dal Piaz, V; Graziano, A; Biagini, P; Ghelardini, C; Galeotti, N; Giovannoni, MP Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action. J Med Chem49:7826-35 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Alpha-2A adrenergic receptor [16-465] |
---|
Name: | Alpha-2A adrenergic receptor [16-465] |
Synonyms: | ADA2A_RAT | Adra2a | Adrenaline 2 | Alpha-2A adrenergic receptor | Alpha-2A adrenoceptor | Alpha-2A adrenoreceptor | Alpha-2AAR | Alpha-2D adrenergic receptor | Alpha2 Adrenoreceptor | CA2-47 | adrenergic Alpha2A |
Type: | G-protein coupled receptor |
Mol. Mass.: | 48961.69 |
Organism: | Rattus norvegicus (rat) |
Description: | P22909[16-465] |
Residue: | 450 |
Sequence: | MGSLQPDAGNSSWNGTEAPGGGTRATPYSLQVTLTLVCLAGLLMLFTVFGNVLVIIAVFT
SRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKVWCEIYLALDVLFCTSS
IVHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIVTVWVISAVISFPPLISIEKKGAGGG
QQPAEPSCKINDQKWYVISSSIGSFFAPCLIMILVYVRIYQIAKRRTRVPPSRRGPDACS
APPGGADRRPNGLGPERGAGTAGAEAEPLPTQLNGAPGEPAPTRPRDGDALDLEESSSSE
HAERPQGPGKPERGPRAKGKTKASQVKPGDSLPRRGPGAAGPGASGSGQGEERAGGAKAS
RWRGRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLIAVGCPVPYQLFNFFFWFGYCNSS
LNPVIYTIFNHDFRRAFKKILCRGDRKRIV
|
|
|
BDBM50201046 |
---|
n/a |
---|
Name | BDBM50201046 |
Synonyms: | 5-{3-[4-(3-chlorophenyl)hexahydro-1-pyrazinyl]propyl}-3-methyl-7-phenyl-4,5-dihydroisoxazolo[4,5-d]pyridazin-4-one | 5-{[4-(3-chlorophenyl)piperazin-1-yl]propyl}-3-methyl-7-phenylisoxazolo[4,5-d]pyridazinon-4-(5H)-one | CHEMBL10161 |
Type | Small organic molecule |
Emp. Form. | C25H26ClN5O2 |
Mol. Mass. | 463.959 |
SMILES | Cc1noc2c(nn(CCCN3CCN(CC3)c3cccc(Cl)c3)c(=O)c12)-c1ccccc1 |
Structure |
|